Searched for
SIDDHARTH SHAH PHARMEASY
Pharmeasy founder Siddharth Shah steps down as CEOPharmeasy founder Siddharth Shah has stepped down as the chief executive to assume the role of vice chairman of the company's board. Rahul ...- PharmEasy founders make interior design and architecture foray with All HomeThree of PharmEasy's founders — Dharmil Sheth, Dhaval Shah, and Hardik Dedhia — have launched All Home, an architectural and interior desig...
- PharmEasy to formally discuss IPO plans with its board in second trySources told ET that online pharmacy startup PharmEasy could hit the bourses this year, two years after its previous attempt. The company w...
- PharmEasy halves loss to Rs 2,533 crore in FY24, revenue dips 15%Mumbai-based PharmEasy, operated by API Holdings Limited, reported a net loss of Rs 2,533 crore, an improvement from the Rs 5,212 crore los...
- PharmEasy CEO has three-year lock-in, Ranjan Pai to get three board seatsPai is also joining the board of PharmEasy and is expected to work with CEO Shah. He will retain the board seats as long as his holding doe...
- Goldman may convert part-debt into equity in PharmEasyThe online pharmacy is also in talks to restructure debt terms ahead of rights issue; share sale set to open on September 4
- PharmEasy valuation crash may not hit Thyrocare founder Velumani’s stakePharmEasy is faced with a steep cut in its valuation, with the new funding round pegging its shares at Rs 5 each compared to the Rs 50 per ...
- PharmEasy parent seeks shareholder nod to increase authorised share capitalThe board notified its shareholders about increasing the authorised share capital to Rs 3,500 crore (about $423.72 million), divided into 3...
- PharmEasy delays IPO, targets Ebitda breakeven by next yearThe Mumbai-based firm is also stitching up a private financing round through a rights issue where company founders are expected to invest p...
- PharmEasy may have to rework IPO valuation as street mood swingsUnlike Delhivery and Oyo Hotels & Homes, its IPO is fully through primary share sale and doesn’t have an OFS (offer for sale) component. It...
- Tata-owned 1mg, PharmEasy go offline for omnichannel presenceTata-owned 1mg is set to open its first physical store in Gurugram next month while rival PharmEasy has started to expand across the offlin...
- PharmEasy closes pre-IPO funding round at $5.6 billion valuationPharmEasy founders — Siddharth Shah, Dhaval Shah, Dhramil Sheth, Harsh Parekh and Hardik Dedhia — have received new stock options ahead of ...
- PharmEasy acquires Aknamed in $180-$190 million stock dealThe acquisition, which is similar to its purchase of Thyrocare in June, is part of the Mumbai-based company’s plans to position itself as a...
- Pre-IPO bout to value PharmEasy at $6 billionTalks on with Amansa, Blackstone, OrbiMed and others as e-pharmacy eyes IPO at $7-8 billion valuation.
- PharmEasy parent API Holdings strengthens board ahead of IPOAPI Holdings — the parent company of PharmEasy — has appointed five independent directors to its board. India's biggest online pharmacy is ...
- PharmEasy co-founder Siddharth Shah buys Rs 40-crore apartment in Mumbai's KharSiddharth Shah, an IIM-Ahmedabad graduate is chief executive of API Holdings that runs PharmEasy, which was in the news recently after it a...
- Pharmeasy in funding talks with SoftBank after Thyrocare dealPharmeasy’s parent API Holdings is seeking a valuation of at least $5.6 billion in a new funding round. SoftBank could invest $150 million ...
- ETtech Exclusive: PharmEasy gets $300 million booster shot for Thyrocare dealPharmEasy has raised $300 million more, bringing the total funding received by the online pharmacy since April to $650 million, most of whi...
- PharmEasy to acquire 66% stake in Thyrocare for over Rs 4,500 crorePharmEasy is acquiring a majority stake in diagnostics chain Thyrocare Technologies, in what the online pharmacy claimed was the first ever...
- PharmEasy to acquire 66% stake in Thyrocare Tech, to make open offer to grab additional 26%PharmEasy claims to be India’s number one online pharmacy and diagnostics brand. Thyrocare prides itself as the largest diagnostic company.
Load More
